The investment objective of the Fund is to provide exposure to the global artificial intelligence technology industry. In order to achieve this investment objective, the Fund will seek to track the ...

SimBioSys announced on October 15, 2026 that the U.S. Food and Drug Administration has granted 510(k) clearance to TumorSight Risk, an artificial intelligence software device that analyzes breast MRI ...

Studies show that artificial intelligence can distort memories, raising questions about what happens when machines become ...

Taiwan Semiconductor Manufacturing Co. is exploring potential investments in Texas to expand chip production in the U.S. The company says it is open to collaborating with Elon Musk’s planned “Terafab” ...

ADCIS 2026 brought together researchers and industry experts to discuss AI, machine learning and data-driven computing, ...

Return to Real pairs wool’s performance story with Ipsos research showing a preference for natural fibers across five markets ...

From the FBI to local police departments, US authorities are increasingly warning of would-be terrorists using AI to plan attacks and anti-datacenter extremism ...

The actively managed Sub-Fund is a dynamic fund seeking long-term performance through exposure on growth securities in international markets. Particularly the Sub-Fund seeks to invest in companies ...

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you ...

Apply a culturally responsive and reflexive lens that respects First Nations knowledges. Research released this year found ...

SWI Group paid $500 million for a 77% stake in Genesis Digital Assets, turning FTX's former Bitcoin-mining sites into AI infrastructure.

What is "Can Artificial Intelligence Really Do That?"? Overview of the BookYutaka Matsuo and Makoto Shiono discuss the ...